Back to search

Article

Patient-reported endometriosis symptom change during GLP-1 receptor agonist use, and its relationship to weight loss: an international cross-sectional survey (GLEAM)

2026-07-14

Abstract excerpt

<title>Abstract</title> <p>Background. Patient communities report endometriosis and adenomyosis symptom change during glucagon-like peptide-1 receptor agonist (GLP-1 RA) use, including among people who lost little or no weight. A prior international survey documented this improvement signal but did not test whether improvement is independent of weight loss. Because weight loss alone can reduce pelvic and systemic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
530bde99-50b1-5252-a584-4b2ed128bd56
DOI
10.21203/rs.3.rs-10323555/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Patient-reported endometriosis symptom change during GLP-1 receptor agonist use, and its relationship to weight loss: an international cross-sectional survey (GLEAM)DOI 10.21203/rs.3.rs-10323555/v1
Select a neighboring publication to make it the new centre.